ZNF217 can attenuate apoptotic signals resulting from telomere dysfunction and may promote neoplastic transformation and later stages of malignancy.[3] Znf217 was shown to be a prognostic biomarker and therapeutic target during breast cancer progression.[4]
Quinlan KG, Verger A, Yaswen P, Crossley M (Jun 2007). "Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad". Biochimica et Biophysica Acta. 1775 (2): 333–40. doi:10.1016/j.bbcan.2007.05.001. PMID17572303.
Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P (Feb 2001). "The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells". Cancer Research. 61 (4): 1250–4. PMID11245413.
Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R (Feb 2003). "A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes". The Journal of Biological Chemistry. 278 (9): 7234–9. doi:10.1074/jbc.M208992200. PMID12493763.
Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG, Meijer GA (Jul 2003). "Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization". The Journal of Pathology. 200 (3): 320–6. doi:10.1002/path.1359. PMID12845628.
Shimada M, Imura J, Kozaki T, Fujimori T, Asakawa S, Shimizu N, Kawaguchi R (Apr 2005). "Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization". Oncology Reports. 13 (4): 633–41. doi:10.3892/or.13.4.633. PMID15756435.
Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C (Nov 2005). "ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction". Human Molecular Genetics. 14 (21): 3219–25. doi:10.1093/hmg/ddi352. PMID16203743.
Cowger JJ, Zhao Q, Isovic M, Torchia J (May 2007). "Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence". Oncogene. 26 (23): 3378–86. doi:10.1038/sj.onc.1210126. PMID17130829.